More recently, liraglutide, a GLP-1A sharing 97% homology with native GLP-1, was approved as an adjunct to lifestyle therapy in obesity management in adults (3). This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.